Persistent atrial fibrillation: A population based study of patients with their first cardioversion

International Journal of Cardiology

Volumn 92, Issue 2-3, 2003, Pages 145-150

  Lehto, Mika ^a   Kala, Risto ^a  

^a Maria Hospital   (Finland)

Author keywords

Arrhythmia; Atrial fibrillation; Cardioversion; Population based; Treatment

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DILTIAZEM; FLECAINIDE; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; AGE; AGED; AORTA STENOSIS; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CARDIOVERSION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HUMAN; HUMAN TISSUE; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RELAPSE; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0346121593     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00099-8     Document Type: Article

References (28)

1. Lown B., Amarasingham R., Neuman J. New method for terminating cardiac arrhythmias. J Am Med Assoc. 182:1962;548-555.
2. Oram S., Davies J.P.H. Further experience of electrical conversion of atrial fibrillation to sinus rhythm: analysis of 100 patients. Lancet. 1:1964;1294-1298.
3. Bjerkelund C., Orning O.M. An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand. 184:1968;481-491.
4. Szekely P., Sideris D.A., Batson G.A. Maintenance of sinus rhythm after atrial defibrillation. Br Heart J. 32:1970;741-746.
5. Radford M.D., Evans D.W. Long-term results of DC reversion of atrial fibrillation. Br Heart J. 30:1968;91-96.
6. Berry C., Stewart S., Payne E.M., McArthur J.D., McMurray J.J.V. Electrical cardioversion for atrial fibrillation: outcomes in 'real-life' clinical practice. Int J Cardiol. 81:2001;29-35.
7. http://www.acc.org/2002ann_meeting/ssnews/control.htm.
8. Hohnloser S.H., Kuck K.-H., Lilienthal J. Rhythm or rate control in atrial fibrillation - pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet. 356:2000;1789-1794.
9. Eckman M.H., Falk R.H., Pauker S.G. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 158:1998;1669-1677.
10. Catherwood E., Fitzpatrick D., Greenberg M.L., et al. Cost-effectiveness of cardioversion and anti-arrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med. 130:1999;625-636.
11. Dorian P., Paquette M., Newman D., et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J. 143:2002;984-990.
12. Coplen S.E., Antman E.M., Berlin J.A., Hewitt P., Chalmers T.C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 82:1990;1106-1116.
13. Kochiadakis G.E., Igoumenis N.E., Marketou M.E., Kaleboubas M.D., Simantirakis E.N., Vardas P.E. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart. 84:2000;251-257.
14. Roy D., Talajic M., Dorian P., et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med. 342:2000;913-920.
15. Kühlkamp V., Schirdewan A., Stangl K., Homberg M., Ploch M., Beck O.A. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. J Am Coll Cardiol. 36:2000;139-146.
16. Plewan A., Lehmann G., Ndrepepa G., et al. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation. Sotalol vs. bisoprolol. Eur Heart J. 22:2001;1504-1510.
17. Van Gelder I.C., Crijns H.J.G.M., Tieleman R.G., et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 156:1996;2585-2592.
18. Alt E., Ammer R., Lehmann G., et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J. 134:1997;419-425.
19. Dittrich H.C., Erickson J.S., Schneiderman T., Blacky A.R., Savides T., Nicod P.H. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 63:1989;193-197.
20. Verhorst P.M.J., Kamp O., Welling R.C., Van Eenige M.J., Visser C.A. Transoesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol. 79:1997;1355-1359.
21. Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 22:2001;1852-1923.
22. Roijer A., Eskilsson J., Olsson B. Transoesophageal echocardiography- guided cardioversion of atrial fibrillation or flutter. Eur Heart J. 21:2000;837-847.
23. Klein A.L., Grim R.A., Murray R.D., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 344:2001;1411-1420.
24. Weigner M.J., Thomas L.R., Patel U., et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med. 110:2001;694-701.
25. Treatment of atrial fibrillation. Recommendations from a workshop arranged by the Medical Products Agency (Uppsala, Sweden) and the Swedish Society of Cardiology. Eur Heart J. 10:1993;1427-1433.
26. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A.L., Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 98:1995;476-484.
27. Stewart S., Hart C.L., Hole D.J., McMurray J.J.V. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 86:2001;516-521.
28. Frykman V., Beerman B., Rydén L., Rosenqvist M. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J. 22:2001;1954-1959.